the Effect of Implanon on Menstrual Patterns
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Implanon (Etonogestrel).
- Who it may be relevant to
- Registry conditions: Menstrual Irregularities. Basic parameters: No limits · Female.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Center list to be confirmed — check the primary protocol.
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
the Effect of Implanon on Menstrual Patterns According to Timing of Insertion After Delivery
Overview
This study aims to evaluate whether the timing of postpartum Implanon insertion (immediately postpartum, early postpartum, or late postpartum) affects menstrual patterns
Detailed description
* Etonogestrel implants (Implanon) are widely used for postpartum contraception. However, the timing of insertion may influence menstrual patterns, including irregular bleeding, amenorrhea, and prolonged bleeding episodes. Despite the increasing use of immediate postpartum contraception, there is limited research on how the timing of Implanon insertion affects menstrual cycle regulation. * Furthermore, lactation and hormonal changes postpartum may modify the bleeding patterns in women using Implanon, with breastfeeding women experiencing a higher likelihood of amenorrhea due to prolactin-induced suppression of ovulation. * This study aims to fill these gaps by systematically comparing menstrual outcomes based on timing of Implanon insertion postpartum
Interventions
- Other Implanon (Etonogestrel)
implanon is a long acting ,reversible contraceptive implants used to prevent pregnancy
Primary outcome measures
- The Effect of Implanon on Menstrual Patterns According to Timing of Insertion After Delivery [Time frame: baseline]
Eligibility criteria
Inclusion criteria
- Postpartum women opting for Implanon as contraception.
- No contraindications to hormonal contraception.
Exclusion criteria
- . Women with known bleeding disorders.
- Use of other hormonal contraceptives during the study period.
- Postpartum complications such as severe infections or retained products of conception
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: Yes
Study design
- Observational model
- Cohort
Study locations
Center list to be confirmed — check the primary protocol.
Publications
- Mazza D, Harrison C, Taft A, Brijnath B, Britt H, Hobbs M, Stewart K, Hussainy S. Current contraceptive management in Australian general practice: an analysis of BEACH data. Med J Aust. 2012 Jul 16;197(2):110-4. doi: 10.5694/mja11.11599. PMID 22794058
- Richters J, Grulich AE, de Visser RO, Smith AM, Rissel CE. Sex in Australia: contraceptive practices among a representative sample of women. Aust N Z J Public Health. 2003;27(2):210-6. doi: 10.1111/j.1467-842x.2003.tb00810.x. PMID 14696713
- . Product information: Implanon NXT, Schering-Plough Pty Ltd, 12 November 2010
- Product information: Implanon® Implant, Organon (Australia) Pty Ltd, 19 March 2008.
Identifiers
NCT: NCT06936436 · effect of implanon